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Treatment of peri-implantitis with deproteinised bovine bone and tetracycline: a case report
Objective: The objective of this study is to evaluate the use of tetracycline in a patient with peri-im-
plantitis.
Background: Tetracycline is widely used in regeneration procedures owing to its positive effect with bone
graft material, regeneration of extraction socket bone and its traditional antibacterial effect. However,
there have been limited reports on bone graft procedures combined with tetracycline application in peri-
implantitis.
Materials and methods: The detoxification procedure was performed with chlorhexidine and tetra-
cycline, and the defect area was grafted with a 4:1 volume ratio combination of deproteinised bovine bone
mixed with tetracycline.
Results: Soft tissue healing was uneventful, and the treatment yielded improved clinical results with a
reduced probing depth.
Conclusions: Tetracycline was used in the treatment of peri-implantitis by burnishing the implant surface
and applying tetracycline in conjunction with an osseous graft to the defect area. The treatment of peri-
implantitis with tetracycline seemed to show improved clinical results up to the follow-up period.
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Introduction
Surgical treatment procedures of peri-implantitis
around titanium implants have previously been
evaluated in humans1–3 and animals4,5, and pro-
tocols such as air-powder abrasives6, citric acid7
and antimicrobial agents8 have been suggested for
the detoxification procedures.
Tetracylines are primarily bacteriostatic antimi-
crobials, which exert their antibacterial activity by
inhibiting microbial protein synthesis9. Tetracycline
is usedwidely in the regenerationprocedure because
of its positive effect with bone graft material10,11, its
regeneration of extraction socket bone12, its tradi-
tional antibacterial effect13 and its anticollagenase
activity14. However, there have been limited reports
on bone graft procedures combined with tetracy-
cline application in peri-implantitis15.
The objective of this case report of a patient with
peri-implantitis is to evaluate the use of tetracy-
cline. We do so by burnishing the implant surface
and applying tetracycline in conjunction with an
osseous graft in the defect area.
Case
A 48-year-old man presented to the Dental Clinic
at the Armed Forces Capital Hospital seeking
treatment for his lower left molar area. The patient
had a non-contributory medical history.
Clinical examination revealed that his two lower
left molars were missing. There was a ridge defect
of the buccal area on the most mesial aspect and
the keratinised tissue on the buccal side measured
1 mm wide. Treatment with a dental implant was
planned after consultation with the patient about
his condition, treatment period and complications.
Three implants (Neoplant, Neobiotech; Seoul,
Korea) were placed in the lower left sextant with
an insertion torque of 40 Ncm (Fig. 1). The defect
of 5 mm (mesio-distal) · 5 mm (apico-coronal)
on the most mesial implant was grafted with
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deproteinised bovine bone (Bio-Oss; Geistlich
Pharm AG, Wolhausen, Switzerland) (Fig. 2). A
healing cap with 2.0 mm label bevel height was
connected, and a portion of the healing cap was left
exposed to avoid tension on the incision line. The
patient was placed on amoxicillin 500 mg, three
times a day for 5 days, mefenamic acid 500 mg
initially, then mefenamic acid 250 mg four times a
day for 5 days, and chlorhexidine digluconate
0.12% three times a day for 4 weeks. The patient
was asked not to chew and brush the surgical area
for the first 4 weeks post-operatively.
The abutments were connected, and final
implant-supported crowns for the lower first and
second molars were inserted 4 months after
implant installation (Fig. 3). Soft tissue healing was
uneventful on the most mesial implant with kera-
tinised tissue on the buccal side measuring
2–3 mm.
The patient came to the clinic complaining of pus
discharge and swelling 2 months after prosthesis
connection. Clinical examination revealed an
8-mm pocket defect with exudates coming through
the gingiva (Fig. 4). A periapical radiograph dem-
onstrated an intrabony defect involving up to three
threads of the most mesial implant (Fig. 5). The
Figure 1 Buccal view at the installation of implants.
Figure 2 Graft material was placed on the defect area.
Figure 3 A 4-month post-operative occlusal view dem-
onstrates good soft tissue healing.
Figure 4 The patient presented with swelling and pus
discharge 2 months after prosthesis connection, which
was 6 months after implant installation.
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granulation tissue was removed with plastic
curettes to minimise damage to the fixture surface.
Wound dehiscence extended apically, with a total
of three exposed threads (Fig. 6). All remaining
tissue tags were carefully removed, and once the
implant surface was visibly free of any debris and
tissue tags, the surface was washed copiously with
saline and chlorhexidine. The surface was then
burnished with tetracycline solution on a cotton
pledget for 2 min. The 6.5 mm (mesio-distal) ·
7.0 mm (apico-coronal) defect was then packed
with deproteinised bovine bone (Bio-Oss; Geist-
lich Pharm AG, Wolhausen, Swizerland) and a 4:1
volume ratio of tetracycline (Evans et al.) (Fig. 7).
Sutures were placed, and the patient was pre-
scribed amoxicillin 500 mg three times a day for
7 days, mefenamic acid 500 mg initially, then
mefenamic acid 250 mg four times a day for 7 days,
and chlorhexidine digluconate 0.12% three times a
day for 4 weeks. No removal of the prosthesis was
intended.
Soft tissue healing was uneventful and probing
depth at the final examination was 5 mm, dem-
onstrating that the treatment produced improved
Figure 5 Radiograph demonstrating a defect area
around the implant.
Figure 7 The defect area is filled with tetracycline and
deproteinised bovine bone after irrigation with chlorh-
exidine and application of tetracycline.
Figure 8 Clinical view 4.5 months after treatment of
peri-implantitis. The soft tissue shows uneventful heal-
ing.
Figure 6 The granulation tissue is removed, revealing a
6.5 mm (mesio-distal) · 7.0 mm (apico-coronal) defect
on the most mesial implant.
Figure 9 Radiograph taken 4.5 months after treatment
of peri-implantitis. The defect area shows stable results
up to the follow-up period.
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clinical results (Fig. 8). A periapical radiograph
taken 4.5 months after the treatment of peri-
implantitis demonstrated increased radiopacity
(Fig. 9), and the patient was scheduled for a follow-
up visit every 6 months.
Discussion
This case report shows the successful management
of peri-implantitis with tetracycline. Surface
debridement of the fixture is an important step
and needs to be carried out with extreme care to
prevent damage to the fixture surface16. Plastic
curettes were used in this report for mechanical
cleaning to remove granulation tissue because they
provide less implant surface alteration17. However,
there are other reports of treatments that utilise
titanium or graphite curettes16,18.
Detoxification of the implant surface was per-
formed using irrigation with chlorhexidine19 and
burnishing of tetracycline. The concentration of
burnishing was 50 mg/ml tetracycline, as used in
the treatment of intrabony periodontal defects20,
and the tetracycline solution was applied to the
implant surface using cotton pledgets for 2 min as
used in the treatment of a furcation defect21.
However, there are other reports suggesting that
cotton pellets and saline may be adequate for the
treatment of rough implant surfaces22.
After the debridement and detoxification proce-
dure, the remaining defect area was filled with
deproteinised bovine bone and a 4:1 volume ratio
of tetracycline used in the treatment of furcation
defect and localised juvenile periodontitis21,23.
Graft material was used because bone graft to
supplement surgical curettage in peri-implant
infection has been reported to show adjunctive
effects24. Park et al.15 reported successful manage-
ment of a rapidly developing periapical implant
lesions caused by an undetected retained root tip.
The apical area was filled with demineralised
freeze-dried bone allograft mixed with 250-mg
tetracycline; however, the ratio was not described.
There is another report showing the potential of
tetracycline for decontamination. Bone samples
undergoing implant osteotomy procedures were
collected in osseous coagulum traps and rinsed
with 50 ml/ml tetracycline, and the authors
reported that tetracycline treatment caused a
sevenfold decrease in streptococci25.
Membranes were not used in this report because
they are prone to exposure, particularly around
implant areas. In a study carried out by Grunder
et al.26, half of the subjects reported premature
membrane exposure occurring between the second
and third post-operative week, which led to the
removal of the membrane secondary to inflam-
mation of the peri-implant tissue. A non-sub-
merged technique was used in this case because of
the difficulty covering the non-submerged implant.
In addition, the results of limited studies comparing
submerged vs. non-submerged techniques have
failed to present any convincing evidence that
a submerged technique is superior26,27. There is
another report evaluating the effect of local
tetracycline delivery on the treatment of peri-
implantitis28. The authors treated 30 lesions
with mechanical debridement and placement of
tetracycline fibres and subsequently reported mean
improvements in clinical parameters28.
Conclusions
Tetracycline was used in the treatment of
peri-implantitis by burnishing the implant surface
and applying tetracycline in conjunction with
an osseous graft to the defect area. The treatment
of peri-implantitis with tetracycline seemed to
show improved clinical results in the follow-up
period.
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